Keyphrases
Breast Cancer
100%
Estrogen Receptor
100%
Antiestrogen
100%
Estrogen Receptor-negative
100%
Mitogen-activated Protein Kinase
33%
Breast Cancer Cell Lines
19%
Re-expression
19%
Tumor
14%
Epidermal Growth Factor Receptor
9%
Estrogen Receptor Status
9%
U0126
9%
Protein Kinase Inhibitors
9%
C-erbB-2
9%
Western Blotting
4%
Breast Cancer Patients
4%
Quantitative PCR
4%
Overexpression
4%
Breast Tumor
4%
Herceptin
4%
Receptor-interacting Protein Kinase 1 (RIPK1)
4%
Estrogen Therapy
4%
Hyperactivity
4%
Protein Kinase Activity
4%
Better Prognosis
4%
Tumor Specimens
4%
Growth Assay
4%
Epithelial Cultures
4%
Iressa
4%
Mitogen-activated Protein Kinase Inhibitor
4%
Hormonal Therapy
4%
Tumor Cell Culture
4%
WST-1
4%
Cell Tumor
4%
Medicine and Dentistry
Breast Cancer
100%
Antiestrogen
100%
Estrogen Receptor
100%
Mitogen-Activated Protein Kinase
29%
Neoplasm
20%
Breast Cancer Cell Line
16%
Receptor Expression
8%
Epidermal Growth Factor Receptor
8%
U0126
8%
Breast Tumor
4%
Hormone Therapy
4%
Western Blot
4%
Gefitinib
4%
Hyperactivation
4%
Tumor Cell Culture
4%
Mitogen Activated Protein Kinase Inhibitor
4%
Cell Line
4%
Trastuzumab
4%
Messenger RNA
4%
Reverse Transcription Polymerase Chain Reaction
4%
Pharmacology, Toxicology and Pharmaceutical Science
Estrogen Receptor
100%
Breast Cancer
100%
Antiestrogen
100%
Mitogen Activated Protein Kinase
29%
Neoplasm
25%
1,4 Diamino 1,4 Bis(2 Aminophenylthio) 2,3 Dicyanobutadiene
8%
Epidermal Growth Factor Receptor
8%
Cell Culture
4%
Western Blot
4%
Hormone Cancer Therapy
4%
Breast Tumor
4%
Gefitinib
4%
Mitogen Activated Protein Kinase Inhibitor
4%
Trastuzumab
4%
Messenger RNA
4%